Is the ‘Weight’ Over? Next Generation of Anti-Obesity Therapeutics



Date & Location
Monday, January 16, 2023, 8:00 AM - Monday, January 15, 2024, 11:59 PM

Credits
AMA PRA Category 1 Credits™ (0.50 hours), AMA PRA Category 1 Credits™ Designated (0.50 hours)

Target Audience
Specialties - Family Medicine, Internal Medicine
Professions - Dieticians and Nutrionists, Non-Physician, Nurse, Nurse Practitioner, Other Healthcare Professionals, Physician, Physician Assistant/Associate, Physicians In Training

Overview
Obesity affects 600 million people globally and over one third of the American population. Along with associated comorbidities, including cardiovascular disease, stroke, diabetes, and cancer; the direct and indirect costs of managing obesity are 21% of the total medical costs. The elevated risk for severe disease and death from COVID-19 associated with obesity and its comorbidities underscores the urgency to develop and implement effective prevention and treatment strategies.  Current strategies for treating obesity rely on a "one-size-fits-all" approach despite significant pathophysiological heterogeneity among people with obesity. As a result, the response to obesity pharmacotherapy as well as diet and lifestyle interventions continues to be a hit-or-miss phenomenon with highly variable efficacies and outcomes. Currently available drugs only offer a 5% weight loss (in comparison to placebo) if both drug and placebo are given with a lifestyle intervention. However, we are now seeing the emergence of second-generation medications. Knowledge of the safety and efficacy of newly available therapeutic options is vital to health care practitioners as they work with patients to develop optimal, individualized, and long-term strategies for overcoming obesity.

Registration

There are no fees for participating in and receiving CME credit for this online activity. 

To participate in this activity, register with ReachMD.

This activity can be accessed using the following url: https://reachmd.com/programs/cme/is-the-weight-over-next-generation-of-anti-obesity-therapeutics/14590/


Objectives
As a result of participating in this activity, participants should be able to:

  1. Discuss strategies/tools to screen and diagnose, and review barriers for discussion of weight during visits;
  2. Distinguish and identify newly available and emerging therapeutic approaches to obesity;
  3. Incorporate obesity counseling as a tool for patient education and engagement in weight management.

Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and CORE Medical Education, LLC. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of .5 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Additional Information

Disclosure of Ineligible Relationships (COI) Policy

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education and the University of Cincinnati policy, all faculty, planning committee members, and other individuals, who are in a position to control content, are required to disclose all relationships with ineligible companies* (commercial interests) within the last 24 months. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. The ACCME requires us to disqualify from involvement in the planning and implementation of accredited continuing education any individuals (1) who refuse to provide this information or (2) whose conflicts of interests cannot be mitigated.

All relevant relationships have been mitigated. The following disclosures were made:

Medical Director & Program Planners

CORE Medical Education, LLC

Otto Ratz, MD
Christina Culbert, MSc

CORE Medical Education staff do not have any relationships to report.

University of Cincinnati Center for Continuous Professional Development/CME

Bruce Gebhardt, MD, Physician Reviewer
Susan P. Tyler, PhD, CHCP, Associate Dean
Heather Muskopf, Program Manager

University of Cincinnati staff do not have any relationships to report.

Disclaimer Statement
The opinions expressed during the endured activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati or CORE Medical Education. The information is presented for the purpose of advancing the attendees’ professional development.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati nor CORE Medical Education, LLC, recommends the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Learner Assurance Statement
The University of Cincinnati is committed to mitigating all conflicts of interest issues that could arise as a result of prospective faculty members’ relationships with ineligible companies. The University of Cincinnati is committed to retaining only those speakers with financial interests that can be mitigated as they relate to the goals and educational integrity of the CME activity.